Loading the player...
Information
Decoding Thyroid Cancer: Unraveling the Impact of Epigenetics on Development, Tumor Microenvironment, and Immune Response
Accreditation
The American Thyroid Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
The American Thyroid Association designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Information
In accordance with the ACCME Accreditation Criteria, the American Thyroid Association ensures that anyone in a position to control the content of the educational activity (planners/speakers/authors/discussants/moderators) disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”) held in the last 24 months. No faculty have financial disclosures.
The ACCME also requires that ATA manage any reported relevant financial relationships and eliminate the potential for bias during the educational activity. Any relevant financial relationships noted have been mitigated. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Salma Khan, MBBS, PhD – Co-Chair
Mabel M. Ryder, MD – Co-Chair
Mabel M. Ryder, MD is an Endocrinologist and Assistant Professor of Medicine at Mayo Clinic, Rochester. She completed her residency and endocrine fellowship at the University of Cincinnati College of Medicine. Dr. Ryder’s interests are endocrine cancers, thyroid disease and cancer, adrenal disorders and cancer, and the role of tumor microenvironment in facilitating thyroid cancer progressions. She is a member of the American Thyroid Association and International Thyroid Oncology Group.
